- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about AZN
Recent news which mentions AZN
These 2 Numbers Could Spell Trouble for AbbVie Stock
May 24, 2022
From Motley Fool
From Benzinga
From Benzinga
3 Monkeypox Stocks That Soared Last Week
May 23, 2022
From Motley Fool
2 Safe Stocks to Buy in a Bear Market
May 21, 2022
From Motley Fool
From Benzinga
5 Stocks to Buy for the Coming Recession
May 18, 2022
From InvestorPlace
From Benzinga
From Benzinga
U.S. COVID cases at highest levels since November, while Northeast and Midwest are above delta peak
May 16, 2022
Tickers
AZN
From MarketWatch
From Benzinga
White House Says Currently No Plans To Share COVID-19 Shots With North Korea Battling Outbreak
May 13, 2022
From Benzinga
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
Why GSK May Have Bet Too Big on a Pandemic Pipeline
May 07, 2022
From Motley Fool
PR Agency Tells Blue-Chip Clients Like AT&T, Coca-Cola, Netflix And More To Avoid Media Inquiries On Abortion Debate
May 06, 2022
From Benzinga
3 Top Biotech Stocks to Buy Right Now
May 06, 2022
From Motley Fool
3 Nasdaq 100 Stocks to Buy Hand Over Fist in May
May 06, 2022
From Motley Fool
FDA Approval For AstraZeneca - Daiichi's Enhertu Expands To Earlier Use In Metastatic Breast Cancer
May 05, 2022
From Benzinga
From Benzinga
From Benzinga
FDA Accepts AstraZeneca's sBLA for Imfinzi (durvalumab) in biliary tract cancer (BTC) with Priority Review
May 04, 2022
From Benzinga
From Benzinga
From Benzinga
1 Top Dividend Stock to Buy and Hold Forever
May 01, 2022
From Motley Fool
Read Why This Analyst Is 'Encouraged' By Seagen's Q1 Sales
April 29, 2022
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.